{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:03:41Z","timestamp":1768719821349,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"canadian institute for health research","doi-asserted-by":"crossref","award":["407589"],"award-info":[{"award-number":["407589"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>People experiencing asthma exacerbations are at increased risk of cardiovascular events. To better understand the relationship between asthma exacerbations and cardiovascular risk, this randomized case-control, cross-over controlled trial assessed the immediate systemic inflammatory and vascular responses to acutely induced pulmonary inflammation and bronchoconstriction in people with asthma and controls.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Twenty-six people with asthma and 25 controls underwent three airway challenges (placebo, mannitol, and methacholine) in random order. Markers of cardiovascular risk, including serum C-reactive protein, interleukin-6, and tumor necrosis factor, endothelial function (flow-mediated dilation), microvascular function (blood-flow following reactive hyperemia), and arterial stiffness (pulse wave velocity) were evaluated at baseline and within one hour following each challenge. The systemic responses in a) asthma\/control and b) positive airway challenges were analyzed. (ClinicalTrials.gov reg# <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02630511\" xlink:type=\"simple\">NCT02630511<\/jats:ext-link>)<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Both the mannitol and methacholine challenges resulted in clinically significant reductions in forced expiratory volume in 1 second (FEV<jats:sub>1<\/jats:sub>) in asthma (-7.6% and -17.9%, respectively). Following positive challenges, reduction in FEV<jats:sub>1<\/jats:sub> was -27.6% for methacholine and -14.2% for mannitol. No meaningful differences in predictors of cardiovascular risk were observed between airway challenges regardless of bronchoconstrictor response.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Neither acutely induced bronchoconstriction nor pulmonary inflammation and bronchoconstriction resulted in meaningful changes in systemic inflammatory or vascular function. These findings question whether the increased cardiovascular risk associated with asthma exacerbations is secondary to acute bronchoconstriction or inflammation, and suggest that other factors need to be further evaluated such as the cardiovascular impacts of short-acting inhaled beta-agonists.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0288623","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:27:25Z","timestamp":1689614845000},"page":"e0288623","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of airway challenges on cardiovascular risk in asthma \u2013 a randomized controlled trial"],"prefix":"10.1371","volume":"18","author":[{"given":"Linn E.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Brotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desi P.","family":"Fuhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda J.","family":"Rosychuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-4760","authenticated-orcid":true,"given":"Michael K.","family":"Stickland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"pone.0288623.ref001","volume-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2016"},{"key":"pone.0288623.ref002","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ije\/dyh081","article-title":"Are patients with asthma at increased risk of coronary heart disease?","volume":"33","author":"C Iribarren","year":"2004","journal-title":"Int J Epidemiol"},{"key":"pone.0288623.ref003","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/aje\/kws181","article-title":"Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts","volume":"176","author":"C Iribarren","year":"2012","journal-title":"American journal of epidemiology"},{"key":"pone.0288623.ref004","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ije\/25.3.617","article-title":"Do patients with severe asthma run an increased risk from ischaemic heart disease?","volume":"25","author":"K Toren","year":"1996","journal-title":"Int J Epidemiol"},{"key":"pone.0288623.ref005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2013.10.021","article-title":"Increased arterial stiffness in stable and severe asthma","volume":"108","author":"WX Sun","year":"2014","journal-title":"Respir Med"},{"key":"pone.0288623.ref006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/JAS-120026073","article-title":"Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes","volume":"41","author":"P Yildiz","year":"2004","journal-title":"J Asthma"},{"key":"pone.0288623.ref007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rmed.2009.09.004","article-title":"Pulmonary function correlates with arterial stiffness in asthmatic patients","volume":"104","author":"Z Weiler","year":"2010","journal-title":"Respir Med"},{"key":"pone.0288623.ref008","first-page":"561831","article-title":"Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma","volume":"2013","author":"JC Mak","year":"2013","journal-title":"ISRN Allergy"},{"key":"pone.0288623.ref009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaip.2019.06.043","article-title":"Risk of Acute Myocardial Infarction and Ischemic Stroke in Patients with Asthma Exacerbation: A Population-Based, Self-Controlled Case Series Study","volume":"8","author":"Y Raita","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"pone.0288623.ref010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.rmed.2008.10.003","article-title":"High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma","volume":"103","author":"Z Zietkowski","year":"2009","journal-title":"Respir Med"},{"key":"pone.0288623.ref011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study","volume":"1","author":"PW Wilson","year":"2008","journal-title":"Circulation Cardiovascular quality and outcomes"},{"key":"pone.0288623.ref012","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"PM Ridker","year":"2000","journal-title":"Circulation"},{"key":"pone.0288623.ref013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1378\/chest.11-1838","article-title":"The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma","volume":"142","author":"LG Wood","year":"2012","journal-title":"Chest"},{"key":"pone.0288623.ref014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.vph.2010.09.005","article-title":"Pulmonary allergic reactions impair systemic vascular relaxation in ragweed sensitive mice","volume":"53","author":"S Hazarika","year":"2010","journal-title":"Vascul Pharmacol"},{"key":"pone.0288623.ref015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1165\/rcmb.2009-0427OC","article-title":"Particulate matter induces translocation of IL-6 from the lung to the systemic circulation","volume":"44","author":"T Kido","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"pone.0288623.ref016","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.102.9.994","article-title":"Acute systemic inflammation impairs endothelium-dependent dilatation in humans","volume":"102","author":"AD Hingorani","year":"2000","journal-title":"Circulation"},{"key":"pone.0288623.ref017","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1161\/CIRCULATIONAHA.105.535435","article-title":"Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals","volume":"112","author":"C Vlachopoulos","year":"2005","journal-title":"Circulation"},{"key":"pone.0288623.ref018","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1183\/09031936.03.00113403","article-title":"Evidence of mast cell activation and leukotriene release after mannitol inhalation","volume":"22","author":"JD Brannan","year":"2003","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref019","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/japplphysiol.00978.2010","article-title":"The occurrence of refractoriness and mast cell mediator release following mannitol-induced bronchoconstriction","volume":"110","author":"J Larsson","year":"2011","journal-title":"J Appl Physiol (1985)"},{"key":"pone.0288623.ref020","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.rmed.2008.11.009","article-title":"Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity","volume":"103","author":"K Samitas","year":"2009","journal-title":"Respir Med"},{"key":"pone.0288623.ref021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1440-1843.2002.00357.x","article-title":"Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects","volume":"7","author":"JD Brannan","year":"2002","journal-title":"Respirology"},{"key":"pone.0288623.ref022","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.158.4.9802087","article-title":"Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma","volume":"158","author":"JD Brannan","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0288623.ref023","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1155\/2012\/214129","article-title":"Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults: executive summary","volume":"19","author":"MD Lougheed","year":"2012","journal-title":"Canadian respiratory journal"},{"key":"pone.0288623.ref024","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"R Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref025","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"EF Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref026","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"N Macintyre","year":"2005","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref027","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref028","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"J Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"pone.0288623.ref029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/ajrccm.161.1.ats11-99","article-title":"Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999","volume":"161","author":"RO Crapo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0288623.ref030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/ajrccm.156.3.9701113","article-title":"A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol","volume":"156","author":"SD Anderson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0288623.ref031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1358863X12451337","article-title":"The optimal measure of microvascular function with velocity time integral for cardiovascular risk prediction","volume":"17","author":"V Lee","year":"2012","journal-title":"Vasc Med"},{"key":"pone.0288623.ref032","doi-asserted-by":"crossref","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","article-title":"Assessment of flow-mediated dilation in humans: a methodological and physiological guideline","volume":"300","author":"DH Thijssen","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0288623.ref033","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"DJ Green","year":"2011","journal-title":"Hypertension"},{"key":"pone.0288623.ref034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.110.953653","article-title":"Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study","volume":"123","author":"TJ Anderson","year":"2011","journal-title":"Circulation"},{"key":"pone.0288623.ref035","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"S Laurent","year":"2006","journal-title":"European heart journal"},{"key":"pone.0288623.ref036","article-title":"European Medicine Agency","year":"2015","journal-title":"Guideline on adjustment for baseline covariates in clinical trails"},{"key":"pone.0288623.ref037","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"C Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"pone.0288623.ref038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.resp.2016.05.014","article-title":"Short-term cardiovascular and autonomic effects of inhaled salbutamol","volume":"231","author":"H Edgell","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"key":"pone.0288623.ref039","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaci.2008.10.032","article-title":"North West Adelaide Cohort Health Study T. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists","volume":"123","author":"SL Appleton","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0288623.ref040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1164\/ajrccm.161.3.9904006","article-title":"The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists","volume":"161","author":"DH Au","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0288623.ref041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rmed.2019.07.018","article-title":"Acute effects of salbutamol on systemic vascular function in people with asthma","volume":"155","author":"LE Moore","year":"2019","journal-title":"Respir Med"},{"key":"pone.0288623.ref042","first-page":"1455","article-title":"Age as a risk factor: you are as old as your arteries","volume":"83","author":"SM Grundy","year":"1999","journal-title":"Am J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:27:50Z","timestamp":1689614870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288623"}},"subtitle":[],"editor":[{"given":"Davor","family":"Plavec","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288623","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}